Incorporation of luciferase reporter system also results in transcription activity of NF-κB in lung cancer cells treated with compound 17 or compound 18 and demonstrated that relative luciferase expression was significantly reduced in compound 17 or compound 18 treated lung cancer cells. This evidence concerns the gene NFKB1 and lung carcinoma.